1. Date of Incident: July 9, 2026
2. Company Name: Taisun Enterprise Co., Ltd.
3. Relationship to Company: Parent Company
4. Cross-shareholding Ratio: Not applicable
5. Reason for Incident: On July 9, 2026, the company received instructions from the Central Regional Administration of the Taiwan Food and Drug Administration (FDA) under the Ministry of Health and Welfare. To protect consumer health rights and reduce potential exposure risks, the FDA has ordered that all oil products and their derived goods manufactured by Chung Lian during April, May, and June 2026, must be removed from shelves preventively by 12:00 PM on July 10, 2026.
6. Response Measures: In compliance with regulatory requirements, Taisun has notified all distribution channels on July 9 to conduct a full preventive withdrawal of all products containing oils produced by Chung Lian between April and June. All previously shipped quantities have been accounted for, and current inventory has been fully sealed and will not be dispatched. The withdrawal process will be completed within the timeframe specified by the authorities.
7. Other Matters to be Disclosed: None.
FACT BOX
- Source: PR Times
- Category: News